Trials show that digitoxin—active ingredient in foxglove—lowered mortality & hospitalisation in patients with reduced heart-pumping function, insufficient emptying of left ventricle.
Inclisiran was developed by Novartis & launched in India in January this year under brand name Leqvio. Cardiologist vouch for benefits, say it has been a useful addition to therapies.
Report by Asia-Pacific Society of Cardiology says heart failure burden ranges from 1.3 to 6.7% in South Asian countries. Calls for ‘cancer-level’ urgency to tackle condition.
The US military operation in Venezuela raises global concern. Experts say that Trump’s action could weaken global legal standards and fuel geopolitical instability.
The latest comment comes as New Delhi and Washington have yet to sign a trade agreement. India’s purchase of Russian oil has reduced, but Moscow remains top source for crude.
If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.
Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.
COMMENTS